Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye

Advances in Therapy

Volumn 27, Issue 10, 2010, Pages 681-690

  Springs, Clark L ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dry eye disease; Eye drops; HP guar; Systane; Tear film

Indexed keywords

ARTIFICIAL TEAR; BLINK TEARS; CARBOXYMETHYLCELLULOSE GLYCERIN; EYE DROPS; MACROGOL 400; MACROGOL 400 PROPYLENE GLYCOL HYDROXYPROPYLGUAR; OPTIVE; REFRESH TEARS; SENSITIVE EYES; SYSTANE; UNCLASSIFIED DRUG; HYDROXYPROPYL GUAR; MACROGOL DERIVATIVE; POLYSACCHARIDE; PROPYLENE GLYCOL;

CONTRAST SENSITIVITY; COST OF ILLNESS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY EYE; EYE IRRITATION; FLOW KINETICS; HUMAN; IN VITRO STUDY; LUBRICATION; PH; PREVALENCE; QUALITY OF LIFE; REVIEW; SCHIRMER TEST; SYSTEMATIC REVIEW; TEAR FILM; UNSPECIFIED SIDE EFFECT; VISCOELASTICITY; VISUAL ACUITY; CHEMISTRY;

DRY EYE SYNDROMES; HUMANS; HYDROGEN-ION CONCENTRATION; OPHTHALMIC SOLUTIONS; POLYETHYLENE GLYCOLS; POLYSACCHARIDES; PROPYLENE GLYCOL;

EID: 79952115135     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-010-0052-3     Document Type: Review

References (51)

1. Lemp MA, Foulks GN. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75-92.
2. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114-1119.
3. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124:723-728. (Pubitemid 27523148)
4. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. 1997;74:624-631. (Pubitemid 27432771)
5. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326. (Pubitemid 36904081)
6. Lemp MA, Foulks G, Devgan U, et al. The therapeutic role of lipids: managing ocular surface disease. Refract Eyecare Ophthalmol. 2005;9:3-15.
7. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-1268.
8. Perry HD, Donnenfeld ED. Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol. 2004;15:299-304.
9. Altinors DD, Akca S, Akova YA, et al. Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol. 2006;141:1016-1021.
10. Schlote T, Kadner G, Freudenthaler N. Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use. Graefes Arch Clin Exp Ophthalmol. 2004;242:306-312. (Pubitemid 38647604)
11. Gifford P, Evans BJ, Morris J. A clinical evaluation of Systane. Cont Lens Anterior Eye. 2006;29:31-40. (Pubitemid 43372726)
12. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615-621. (Pubitemid 30327337)
13. Kahook MY, Springs C. Treating ocular surface disease in glaucoma. Glaucoma Today. 2008;11.
14. Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:108-152.
15. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:93-107.
16. Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: comparisons to a US normative sample. Invest Ophthalmol Vis Sci. 2005;46:46-50. (Pubitemid 40041177)
17. Kozma CM, Hirsch JD, Wojcik AR. Economic and quality of life impact of dry eye symptoms. Poster presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology, April 30-May 5, 2000, Ft. Lauderdale, Fla.
18. Tuft S, Lakhani S. Medical management of dry eye disease. Dev Ophthalmol. 2008;41:54-74.
19. Determinants of tear film stability. The Castroviejo Lecture. Presented at: The American Academy of Ophthalmology Annual Meeting. October 15-18, 2005; Chicago, IL, USA.
20. Foulks GN. Clinical evaluation of the efficacy of PEG/PG lubricant eye drops with gelling agent (HP-guar) for the relief of the signs and symptoms of dry eye disease: a review. Drugs Today (Barc). 2007;43:887-896. (Pubitemid 351160484)
21. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res. 2004;78:347-360. (Pubitemid 38183311)
22. Lemp MA. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995;21:221-232.
23. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589. (Pubitemid 28511901)
24. Terry MA. Dry eye in the elderly. Drugs Aging. 2001;18:101-107. (Pubitemid 32269584)
25. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47:4309-4315. (Pubitemid 46579353)
26. Khanal S, Tomlinson A, McFadyen A, Diaper C, Ramaesh K. Dry eye diagnosis. Invest Ophthalmol Vis Sci. 2008;49:1407-1414.
27. Wolkoff P, Nojgaard JK, Troiano P, Piccoli B. Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency. Occup Environ Med. 2005;62:4-12. (Pubitemid 40069453)
28. Ousler GW, Michaelson C, Christensen MT. An evaluation of tear film breakup time extension and ocular protection index scores among three marketed lubricant eye drops. Cornea. 2007;26:949-952. (Pubitemid 47329799)
29. Torkildsen G. The effects of lubricant eye drops on visual function as measured by the inter-blink interval visual acuity decay test. Clin Ophthalmol. 2009;3:501-506.
30. Freudenthaler N, Neuf H, Kadner G, Schlote T. Characteristics of spontaneous eyeblink activity during video display terminal use in healthy volunteers. Graefes Arch Clin Exp Ophthalmol. 2003;241:914-920. (Pubitemid 37527051)
31. Berke A. Blinking frequence and the the thickness of the lipid layer. In: Sullivan DA, Stern GA, Dartt DA, Sullivan RM, Bromberg BB, eds. Lacrimal Gland, Tear Film, and Dry Eye Syndrome 3. New York: Kluwer Academic/Plenum; 2002:513-516. (Pubitemid 36307714)
32. Petricek I, Berta A, Higazy MT, Nemeth J, Prost ME. Hydroxypropyl-guar gellable lubricant eye drops for dry eye treatment. Expert Opin Pharmacother. 2008;9:1431-1436. (Pubitemid 351877526)
33. Tiffany JM. Measurement of wettability of the corneal epithelium. II. Contact angle method. Acta Ophthalmol (Copenh). 1990;68:182-187.
34. American Academy of Ophthalmology. The Eye M.D. Association. American Academy of Ophthalmology Basic and Clinical Science Course, 2005-2006. Section 13, Refractive Surgery, page 5.
35. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol. 2001;45(suppl. 2):S203-S210.
36. Montés-Micó R, Caliz A, Alio JL. Changes in ocular aberrations after instillation of artificial tears in dryeye patients. J Cataract Refract Surg. 2004;30:1649-1652. (Pubitemid 39094371)
37. Montés-Micó R, Caliz A, Alio JL. Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg. 2004;20:243-247. (Pubitemid 38657014)
38. Montés-Micó R, Alio JL, Munoz G, Charman WN. Temporal changes in optical quality of air-tear film interface at anterior cornea after blink. Invest Ophthalmol Vis Sci. 2004;45:1752-1757. (Pubitemid 38868968)
39. Montés-Micó R, Alio JL, Munoz G, Perez-Santonja JJ, Charman WN. Postblink changes in total and corneal ocular aberrations. Ophthalmology. 2004;111:758-767. (Pubitemid 38429674)
40. Toyos R. Ability of Systane Ultra to reduce transient visual degradation. Presented at: American Society for Cataract and Refractive Surgery. April 7-9, 2010; Boston, MA, USA.
41. Huang FC, Tseng SH, Shih MH, Chen FK. Effect of artificial tears on corneal surface regularity, contrast sensitivity, and glare disability in dry eyes. Ophthalmology. 2002;109:1934-1940.
42. Rolando M, Iester M, Macri A, Calabria G. Low spatial-contrast sensitivity in dry eyes. Cornea. 1998;17:376-379. (Pubitemid 28307502)
43. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900-907. (Pubitemid 44763848)
44. Lopez BD, Ubels JL. Artificial tear composition and promotion of recovery of the damaged corneal epithelium. Cornea. 1993;12:115-120. (Pubitemid 23099062)
45. Lopez BD, Ubels JL. Quantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservatives. Curr Eye Res. 1991;10:645-656.
46. Davitt WF, Blooenstein M, Martin A, Christensen MT, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocular Pharmacol Therap. 2010. In press.
47. Hartstein I, Khwarg S, Przydryga J. An open-label evaluation of HP-guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population. Curr Med Res Opin. 2005;21:255-260. (Pubitemid 40469901)
48. Ketelson HA, Davis J, Meadows DL. Characterization of a novel polymeric artificial tear delivery system. Presented at: The Association for Research in Vision and Ophthalmology (ARVO). April 27-May 1, 2008. Fort Lauderdale, Florida, USA.
49. Kading D. A two-week clinical evaluation of the safety of Systane Ultra in contact lens-wearing patients. Clin Ophthalmol. 2010;4:27-32.
50. Springs C. Novel ocular lubricant containing an intelligent delivery system: details of its mechanism of action. In: Brewitt H, ed. Research Project in Dry Eye. Basel: Kager; 2010:139-147.
51. Korb DR, Greiner JV, Herman JP, et al. Lid-wiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J. 2002;28:211-216. (Pubitemid 38269643)